stock - Search News

News

US stock futures edge up on tariff relief

Yahoo Finance · 4h

Stock market today: Dow, S&P 500, Nasdaq futures slip amid rush of earnings, hopes for auto tariff relief

Wall Street is sifting through a rush of earnings reports and economic data, amid hopes for auto tariff relief.

Reuters on MSN · 8h

US stock futures edge up on tariff relief, with earnings and data in focus

U.S. stock index futures were slightly higher on Tuesday as the Trump administration signaled easing tariffs on the auto sector and investors awaited key earnings and economic data for more direction.

MarketWatch on MSN · 1d

U.S. stock futures fall ahead of big week for tech earnings

After an encouraging week for Wall Street, U.S. stock futures fell late Sunday, ahead of a busy slate of quarterly earnings over the coming days.

Trump's 1st 100 days are worst for stock market since Nixon

MarketWatch · 3h

Trump’s first 100 days in office are worst for stock market in half a century

Tuesday marks the 100th day of Trump’s second presidential term. The S&P 500 SPX is poised for its worst first-100-day performance for a new administration in over 50 years.

CNN on MSN · 4h

The stock market is on pace for its worst first 100 days of any presidential term in more than 50 years

The US stock market is on track for its worst first 100 days of any presidential term since President Gerald Ford assumed office in 1974.

NBC News on MSN · 1d

Trump's first 100 days are the worst for the stock market since Nixon

President Donald Trump’s first 100 days in office are the worst for the stock market for the start of a president’s four-year term since the 1970s.

Hims & Hers strikes a deal with Novo Nordisk to sell Wegovy

MarketWatch on MSN · 1h

Hims & Hers’ stock soars after teaming up with Wegovy maker

Health and wellness company, which sold alternatives to weight-loss drugs like Wegovy, is now collaborating with Wegovy-maker Novo Nordisk.

Wall Street Journal · 4h

Hims & Hers to Sell Novo Nordisk’s Wegovy in U.S., Shares Soar

Him & Hers Health and Novo Nordisk are collaborating to offer weight-loss treatment, including access to Wegovy along with other services to treat obesity.

Investopedia on MSN · 1h

Hims & Hers Stock Surges on Wegovy Deal With Novo Nordisk

Key Takeaways Hims & Hers Health shares surged Tuesday as the company announced a partnership with Danish drugmaker Novo Nordisk.Hims & Hers users will have access to Novo Nordisk's Wegovy starting this week,

Stock market on trade watch, Trump to ease automaker tariffs: Live Updates

The Dow and S&P 500 look to notch a sixth day of gains as investors await more trade news and an easing of tariffs on ...

Zuckerberg Vs Musk: Who Lost More Wealth From Their Stock In 2025

Musk lost nearly $100 billion or >20% of his net worth, while Zuckerberg, unlike the crash of 2022, saw his wealth decline by ...

2hon MSN

Tesla Stock Is Stuck. Can Trump’s Auto Tariff Changes Get It Moving Again?

Tesla stock was rising—barely—in early trading Tuesday as shares have suddenly gotten less volatile. Predicting the electric ...

Wells Fargo to buy back up to $40 bln of its common stock

A large majority of Citigroup shareholders has approved CEO's Jane Fraser's 33% pay increase to $34.5 million at a virtual ...

How To Trade CVS Stock Ahead of Earnings?

Entrance to a CVS Pharmacy in Manhattan. (Photo by ... More Erik McGregor/LightRocket via ) LightRocket via Getty Imag ...

39mon MSN

Regeneron Pharmaceuticals Stock Sinks as Eylea Q1 Sales Trail Estimates

Regeneron Pharmaceuticals stock was among the biggest S&P 500 and Nasdaq decliners Tuesday after the biotech firm reported ...

38m

Stock Market Today: Dow Rises; Investors Dig Into Earnings for Tariff Effects

Trump’s tariffs and the trade war with China continue to impact global markets. Follow along for live updates on the Dow, S&P 500, Nasdaq and other markets.

31m

Stock Market News: Dow Chases 6-Day Winning Streak

The Dow is rising, while the S&P 500 and Nasdaq are little changed Tuesday ahead of an expected auto tariffs announcement by President Donald Trump on another busy day of earnings.